Slide
"I am a 45 year old former Ironman...
hoping to avoid a hip replacement at all costs."

- Early OA Patient
Slide
"I am 52, active...young in every way
except my hip"

- Early OA Patient
Slide
"A hip replacement at 35 is nonsense and would
mean the end of my career as a dancer."

- Early OA Patient
Slide

- Dr. Thomas Vail, University of California, San Francisco
"Orthopedic surgeons have been waiting for cartilage resurfacing technology for years. If efficacy can be shown, this technology will rapidly be adopted.”

This is an Untapped Market

People In the United States Suffer From Osteoarthritis

14-55

Age Range: Aimed at Younger Patients Suffering from OA

The Growing Hip Preservation Market is worth Billions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Our Technology?

Expertise and Innovation

Sign up for Business News

Questions

About the

Technology?

Expertise and Innovation

Sign up for Business News

News

2024 OrthoPitch Winner!

2024 OrthoPitch Winner!

We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...

read more
AAOS OrthoPitch 2024

AAOS OrthoPitch 2024

CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...

read more
Newsletter – January 2024

Newsletter – January 2024

The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...

read more

News

2024 OrthoPitch Winner!

2024 OrthoPitch Winner!

We’re super proud of our CEO, Brad Estes, Ph.D., as he impressed the audience and judges alike to lead CytexOrtho to victory at the first inaugural AAOS OrthoPitch competition! Our sincere thanks to MCRA and American Academy of Orthopaedic Surgeons (AAOS) for giving...

read more
AAOS OrthoPitch 2024

AAOS OrthoPitch 2024

CytexOrtho is excited to be selected as a finalist at the inaugural OrthoPitch contest next week at AAOS! CytexOrtho’s CEO, Dr. Brad Estes, will be battling it out with three other startups for the prizes and bragging rights at a brand-new technology competition for...

read more
Newsletter – January 2024

Newsletter – January 2024

The January 2024 issue of the CytexOrtho newsletter covers our 2023 accomplishments, including receiving Breakthrough Device Designation from the FDA, and highlights what is on the horizon in 2024: the plan for hosting our first clinical trial and the launch of our...

read more